James G. Cole, Inc., dba ASN/Maxam Neutraceutics

FDA Regulatory Profile

James G. Cole, Inc., dba ASN/Maxam Neutraceutics appears in FDA public data with 2 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (F-2956-2015, Class II) was initiated on March 6, 2015.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
F-2956-2015Class IIALL MAXAM PRODUCTS: The Maxam product is used orally in spray form and bears the Maxam label. *March 6, 2015
F-2957-2015Class IIALL ASN products: The ASN products are in capsule or powdered form and bear the ASN label. ****March 6, 2015